Scientists test 'Living Drug' to fight advanced skin cancer
Disease control
Ongoing
This early-stage study is testing a two-part treatment for advanced melanoma that has spread. Doctors take a patient's own immune cells from a tumor, grow them in a lab, and then infuse them back, combined with an immunotherapy drug (pembrolizumab). The goal is to see if this app…
Phase: PHASE1 • Sponsor: Richard Wu • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC